Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Calcium is not expected to show acute toxic effects via oral and dermal route.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Based on a weight of evidence, the acute oral toxicity of inorganic calcium salts can safely be assumed to be above the level for classification. No adverse effects in humans are reported up to the upper intake level of 2500 mg/day. Further, two references on (non-guideline compliant) acute oral toxicity in animals do not report any adverse effects leading to a classification as acute orally toxic, thus testing for acute oral toxicity is considered scientifically unjustified for animal welfare reason.


Justification for selection of acute toxicity – oral endpoint
Weight of evidence information.

Justification for classification or non-classification

The available information indicates that inorganic calcium salts are not acutely toxic or harmful. Therefore, classification of inorganic calcium salts for acute toxicity is not warranted.